We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

8060:TSECanon Marketing Japan Incorporated Analysis

Data as of 2026-06-17 - not real-time

SAR 10.52

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Walaa Cooperative Insurance is trading at SAR 10.52, just above its technical support of SAR 9.72 and below the SMA‑200 of SAR 10.81, indicating a neutral price stance. Technical indicators are mildly bullish – the 20‑day SMA sits slightly above the 50‑day SMA, the RSI is at 59 (well below overbought levels), and the MACD histogram is positive – while volume is on an upward trend. Valuation appears attractive, with a forward PE near 5 versus an industry average of 17, and a price‑to‑book below 1, suggesting the stock is priced at a discount. However, the fundamentals are distressed: revenue fell 16%, gross margin is negative, trailing EPS is –0.72 and operating cash flow is strongly negative, leading to a negative ROE and ROA. The company does hold a sizable cash buffer (≈SAR 1.22 bn) and low absolute debt, and forward EPS forecasts turn positive, which could support a recovery. The stock’s beta is slightly negative, volatility is high at 21% over 30 days, and liquidity is moderate given today’s volume is below its 10‑day average. Overall, the price reflects a blend of cheap valuation and significant earnings risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Technical support near current price
  • Bullish MACD but weak earnings
  • Increasing volume but below average

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Forward earnings estimate turning positive
  • Low valuation multiples relative to peers
  • Strong cash position with modest debt

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential sector demand for insurance in Saudi Arabia
  • Regulatory environment remains stable
  • Uncertainty around sustained profitability

Key Metrics & Analysis

Financial Health

Revenue Growth-16.10%
Profit Margin-6.62%
P/E Ratio5.0
ROE-5.27%
ROA-0.94%
Debt/Equity0.61
P/B Ratio0.8
Op. Cash FlowSAR-190954000
Free Cash FlowSAR-694048512
Industry P/E17.2

Technical Analysis

TrendNeutral
RSI59.1
SupportSAR 9.72
ResistanceSAR 11.01
MA 20SAR 10.22
MA 50SAR 9.98
MA 200SAR 10.81
MACDBullish
VolumeIncreasing
Fear & Greed Index90.38

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta-0.31
Volatility21.43%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.